Condition
Bicuspid Aortic Valve (BAV)
Total Trials
6
Recruiting
5
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting5
Enrolling By Invitation1
Clinical Trials (6)
Showing 6 of 6 trials
NCT02306200Recruiting
Cardiovascular Health Improvement Project
NCT06869954Not ApplicableRecruitingPrimary
Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized Trial
NCT06597188Not ApplicableEnrolling By Invitation
TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis
NCT06830499Recruiting
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06802016RecruitingPrimary
A Study of Chinese Congenital Bicuspid Aortic Valve
NCT06657911RecruitingPrimary
Size Up Bicuspid with the LIra MEthod: the SUBLIME Study
Showing all 6 trials